Agilent Technologies Shares Outstanding 2010-2025 | A

Agilent Technologies shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Agilent Technologies shares outstanding for the quarter ending April 30, 2025 were 285M, a 2.73% decline year-over-year.
  • Agilent Technologies 2024 shares outstanding were 0.291B, a 1.69% decline from 2023.
  • Agilent Technologies 2023 shares outstanding were 0.296B, a 1.33% decline from 2022.
  • Agilent Technologies 2022 shares outstanding were 0.3B, a 2.28% decline from 2021.
Agilent Technologies Annual Shares Outstanding
(Millions of Shares)
2024 291
2023 296
2022 300
2021 307
2020 312
2019 318
2018 325
2017 326
2016 329
2015 335
2014 338
2013 345
2012 353
2011 355
2010 353
2009 346
Agilent Technologies Quarterly Shares Outstanding
(Millions of Shares)
2025-04-30 285
2025-01-31 287
2024-10-31 291
2024-07-31 291
2024-04-30 293
2024-01-31 294
2023-10-31 296
2023-07-31 295
2023-04-30 297
2023-01-31 297
2022-10-31 300
2022-07-31 299
2022-04-30 301
2022-01-31 303
2021-10-31 307
2021-07-31 306
2021-04-30 307
2021-01-31 309
2020-10-31 312
2020-07-31 312
2020-04-30 312
2020-01-31 313
2019-10-31 318
2019-07-31 316
2019-04-30 321
2019-01-31 322
2018-10-31 325
2018-07-31 324
2018-04-30 326
2018-01-31 323
2017-10-31 326
2017-07-31 326
2017-04-30 325
2017-01-31 326
2016-10-31 329
2016-07-31 328
2016-04-30 328
2016-01-31 332
2015-10-31 335
2015-07-31 334
2015-04-30 337
2015-01-31 338
2014-10-31 338
2014-07-31 338
2014-04-30 337
2014-01-31 338
2013-10-31 336
2013-07-31 343
2013-04-30 349
2013-01-31 352
2012-10-31 353
2012-07-31 353
2012-04-30 354
2012-01-31 352
2011-10-31 355
2011-07-31 357
2011-04-30 355
2011-01-31 355
2010-10-31 353
2010-07-31 352
2010-04-30 354
2010-01-31 354
2009-10-31 346
2009-07-31 345
2009-04-30 344
2009-01-31 352
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $32.221B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.206B 27.56
Boston Scientific (BSX) United States $152.664B 38.22
Stryker (SYK) United States $149.191B 31.19
EssilorLuxottica (ESLOY) France $131.913B 0.00
Medtronic (MDT) Ireland $115.147B 16.32
Lonza Group Ag (LZAGY) Switzerland $50.094B 0.00
Haleon (HLN) United Kingdom $43.531B 24.85
ResMed (RMD) United States $37.280B 28.00
GE HealthCare Technologies (GEHC) United States $34.547B 16.40
Terumo (TRUMY) Japan $24.355B 31.64
Koninklijke Philips (PHG) Netherlands $23.476B 16.47
Insulet (PODD) United States $20.287B 79.63
Zimmer Biomet Holdings (ZBH) United States $18.641B 11.97
Baxter (BAX) United States $14.559B 10.87
Smith & Nephew SNATS (SNN) United Kingdom $12.951B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.729B 23.42
Lantheus Holdings (LNTH) United States $5.148B 12.99
Perrigo (PRGO) Ireland $3.724B 9.44
Prestige Consumer Healthcare (PBH) United States $3.715B 16.59
Haemonetics (HAE) United States $3.575B 16.28
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.342B 27.77
ICU Medical (ICUI) United States $3.072B 22.66
LeMaitre Vascular (LMAT) United States $1.867B 41.72
QuidelOrtho (QDEL) United States $1.864B 12.82
AtriCure (ATRC) United States $1.504B 0.00
Acuren (TIC) United States $1.431B 0.00
Phibro Animal Health (PAHC) United States $1.238B 15.82
AdaptHealth (AHCO) United States $1.232B 12.51
Green Thumb Industries (GTBIF) United States $1.212B 27.26
Neogen (NEOG) United States $1.068B 13.67
BioLife Solutions (BLFS) United States $1.006B 0.00
InMode (INMD) Israel $0.901B 9.08
Kestra Medical Technologies (KMTS) United States $0.788B 0.00
Curaleaf Holdings (CURLF) Canada $0.670B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.642B 0.00
Owens & Minor (OMI) United States $0.613B 5.08
Tilray Brands (TLRY) Canada $0.607B 0.00
Evolus (EOLS) United States $0.593B 0.00
CeriBell (CBLL) United States $0.571B 0.00
Valneva SE (VALN) France $0.552B 0.00
Surmodics (SRDX) United States $0.446B 0.00
SNDL (SNDL) Canada $0.392B 0.00
Capricor Therapeutics (CAPR) United States $0.331B 0.00
VAREX IMAGING (VREX) United States $0.321B 11.82
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Sanuwave Health (SNWV) United States $0.300B 0.00
Quanterix (QTRX) United States $0.283B 0.00
Cerus (CERS) United States $0.270B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.30
Cresco Labs (CRLBF) United States $0.260B 0.00
Aurora Cannabis (ACB) Canada $0.252B 74.67
Sanara MedTech (SMTI) United States $0.248B 0.00
ZimVie (ZIMV) United States $0.243B 11.04
OraSure Technologies (OSUR) United States $0.239B 0.00
Brainsway (BWAY) Israel $0.230B 60.75
Biote (BTMD) United States $0.224B 6.31
Omeros (OMER) United States $0.206B 0.00
Canopy Growth (CGC) Canada $0.202B 0.00
Verano Holdings (VRNOF) United States $0.200B 0.00
High Tide (HITI) Canada $0.197B 0.00
Organigram Global (OGI) Canada $0.196B 0.00
Utah Medical Products (UTMD) United States $0.183B 14.87
TriSalus Life Sciences (TLSI) United States $0.178B 0.00
Vireo Growth (VREOF) United States $0.152B 0.00
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.123B 15.16
TerrAscend (TSNDF) Canada $0.101B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.100B 12.87
MacroGenics (MGNX) United States $0.096B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Veru (VERU) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Jushi Holdings (JUSHF) United States $0.075B 0.00
Zynex (ZYXI) United States $0.069B 0.00
InterCure (INCR) Israel $0.068B 0.00
Agape ATP (ATPC) $0.068B 0.00
Cytosorbents (CTSO) United States $0.065B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
United-Guardian (UG) United States $0.043B 14.76
Modular Medical (MODD) United States $0.038B 0.00
Safety Shot (SHOT) United States $0.037B 0.00
Nephros (NEPH) United States $0.037B 49.29
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00